Locally Advanced Rectal Cancer - Exfoliated Peritoneal Tumor Cells (LARC-EX)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02113384|
Recruitment Status : Recruiting
First Posted : April 14, 2014
Last Update Posted : October 16, 2015
|Condition or disease||Intervention/treatment|
|Rectal Cancer||Other: Observational study.|
|Study Type :||Observational [Patient Registry]|
|Estimated Enrollment :||160 participants|
|Target Follow-Up Duration:||5 Years|
|Official Title:||Prospective Observational Study of Exfoliated Peritoneal Tumor Cells in Locally Advanced Rectal Cancer|
|Study Start Date :||September 2012|
|Estimated Primary Completion Date :||January 2017|
|Estimated Study Completion Date :||January 2028|
Patients with locally advanced rectum cancer undergoing surgical resection of the primary tumor at the Norwegian Radium Hospital.
Other: Observational study.
Biobanking of tissue (tumor biopsy, peritoneal lavage, blood specimen) from patients with locally advanced rectum cancer undergoing surgical resection of the primary tumor at the Norwegian Radium Hospital.
Other Name: Observational study. Laboratory biomarker analysis.
- Overall survival [ Time Frame: 5 years ]
- Disease-free survival [ Time Frame: 5 years ]
- Disease-free survival [ Time Frame: 3 years ]
- Overall survival [ Time Frame: 3 years ]
Biospecimen Retention: Samples With DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02113384
|Contact: Kjersti Flatmark, MD PhD||+ 47 22 78 18 63||Kjersti.Flatmark@rr-research.no|
|Contact: Annette T Kristensen, PhD||+ 47 22 78 23 email@example.com|
|The Norwegain Radium Hospital||Recruiting|
|Oslo, Ullern, Norway, 0310|
|Contact: Kjersti Flatmark, MD PhD + 47 22 78 18 63 Kjersti.Flatmark@rr-research.no|
|Contact: Annette T Kristensen, PhD + 47 22 78 23 12 firstname.lastname@example.org|
|Principal Investigator: Kjersti Flatmark, MD PhD|
|Principal Investigator: Stein G Larsen, MD PhD|
|Study Chair:||Bjørn-Atle Bjørnbeth, MD PhD||Oslo University Hospital|